Enoxaparin and a new look at clot prevention. 1994

B A Wilson

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D017984 Enoxaparin Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed) Clexane,EMT-966,EMT-967,Enoxaparine,Lovenox,PK-10,169,PK-10169,EMT 966,EMT 967,EMT966,EMT967,PK 10,169,PK 10169,PK10,169,PK10169

Related Publications

B A Wilson
December 1981, Hospital & community psychiatry,
B A Wilson
January 1976, Occupational health & safety (Waco, Tex.),
B A Wilson
August 1999, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
B A Wilson
January 1987, Social science & medicine (1982),
B A Wilson
December 2018, The Journal of family practice,
B A Wilson
January 2007, The American journal of hospice & palliative care,
B A Wilson
July 2000, The Israel Medical Association journal : IMAJ,
B A Wilson
January 1974, Psychological review,
B A Wilson
January 1993, Gynakologisch-geburtshilfliche Rundschau,
Copied contents to your clipboard!